|
Synonyms: Dipeptide 9f [PMID 19175320] | GAP-486 | ZP-123
Compound class:
Peptide
Comment: Rotigaptide (GAP-486, and formerly ZP-123) is a hexapeptide developed originally by Wyeth, as an anti-arrhythmic agent. It promotes electrical coupling between ventricular myocytes by increasing gap junction conductance, via modulation of connexin 43< Reference id=31073/>. A recent study showed reduction in myocardial infarction size in a porcine model and protection from IRI-related endothelial dysfunction in man. Rotigaptide may thus have therapeutic potential in the treatment of myocardial infarction [1].
|
|
|||||||||||||||||
| Bioactivity Comments |
| Promotes electrical coupling between ventricular myocytes by increasing gap junction conductance potentially via alterations in the phosphorylation status of Cx43 (Gap junction alpha-1 protein GJA1, P17302) but the exact mechanism is unknown. |
| Selectivity at ion channels | ||||||||||||||||||||||||||||||||||
| Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||